Boscher C, Nabi IR. Caveolin-1: role in cell signaling. Adv Exp Med Biol.2012;729:29-50. doi: 10.1007/978-1-4614-1222-9_3. Review.
Cao H, Alston L, Ruschman J, Hegele RA. Heterozygous CAV1 frameshift mutations(MIM 601047) in patients with atypical partial lipodystrophy andhypertriglyceridemia. Lipids Health Dis. 2008 Jan 31;7:3. doi:10.1186/1476-511X-7-3.
Garg A, Kircher M, Del Campo M, Amato RS, Agarwal AK; University of WashingtonCenter for Mendelian Genomics. Whole exome sequencing identifies de novoheterozygous CAV1 mutations associated with a novel neonatal onset lipodystrophy syndrome. Am J Med Genet A. 2015 Aug;167A(8):1796-806. doi: 10.1002/ajmg.a.37115.
Kim CA, Delépine M, Boutet E, El Mourabit H, Le Lay S, Meier M, Nemani M,Bridel E, Leite CC, Bertola DR, Semple RK, O'Rahilly S, Dugail I, Capeau J,Lathrop M, Magré J. Association of a homozygous nonsense caveolin-1 mutation withBerardinelli-Seip congenital lipodystrophy. J Clin Endocrinol Metab. 2008Apr;93(4):1129-34. doi: 10.1210/jc.2007-1328.
Quest AF, Lobos-González L, Nuñez S, Sanhueza C, Fernández JG, Aguirre A,Rodríguez D, Leyton L, Torres V. The caveolin-1 connection to cell death andsurvival. Curr Mol Med. 2013 Feb;13(2):266-81. Review.
You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
OK
Confirm
Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?